Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework

Alzheimers Dement. 2018 Apr;14(4):532-534. doi: 10.1016/j.jalz.2018.03.003.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Biomedical Research
  • Drug Development* / methods
  • Humans
  • National Institute on Aging (U.S.)
  • United States
  • Voluntary Health Agencies